Cell and Gene Outsourcing

  1. UpTempo℠: Seamless Transitions From Bench To CGT Applications 6/19/2025

    Accelerate cell and gene therapy development with high-yield, regulatory-compliant plasmid DNA manufacturing that shortens timelines, minimizes risks, and streamlines your supply chain.

  2. Exploring The Market For Closed-Loop Cell Therapy Production 6/18/2025

    The second part of a discussion on closed-loop systems explores the CDMO and equipment landscape for scaling automated closed loop cell therapy manufacturing systems.

  3. Dispelling Common Clinical Trial Oversight Myths 6/17/2025

    Many clinical trial oversight problems can be avoided or mitigated by sponsor understanding root causes and being a proactive collaborator with its partners.

  4. AAV Production: Your AAV CDMO Partner, Every Batch, Every Milestone 6/17/2025

    Confidently navigate every stage of development with tailored tech transfer solutions backed by AAV expertise. Discover how to de-risk, scale, and optimize your process for high-quality performance.

  5. Scaling Up Manufacturing? Here's Why You Need A CMC Specialist 6/16/2025

    CMC experts (whether in-house or outsourced) fill a vital role during the transition from small-scale production to larger operations for maintaining quality, consistency, and compliance.

  6. Why Embrace Diversity, Equity, And Inclusion In The CDMO/Biopharma Sector? 6/16/2025

    Recognizing and integrating diversity, equity, and inclusion (DEI) is essential for fostering innovation, improving team performance, and ensuring long-term competitiveness in a global market.

  7. No Cells, No Limits To DNA Production: Inside Synthetic DNA 6/12/2025

    Here, we walk you through our groundbreaking, enzymatic DNA manufacturing process that enables the production of linear DNA templates for IVT mRNA synthesis — without the use of cells.

  8. Services Designed To Take You From Molecule To Market 6/12/2025

    Accelerate your biopharma journey with a comprehensive service portfolio designed to speed development, reduce costs, and minimize risk from molecule to market.

  9. Crafting Scalable Solutions For Maximum Reach And Success 6/12/2025

    Is your supply chain ready for a blockbuster cell and gene therapy launch? Industry leaders discuss selecting partners, managing risk, and scaling operations for maximum reach and success.

  10. Slow The Burn: How To Make Risk-Resilient Vendor Choices 6/11/2025

    Learn how to identify common CRO selection pitfalls and apply expert-backed strategies to protect your clinical program from costly risks and delays.